{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:31Z","timestamp":1786982131248,"version":"build-2736575974"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s11908-020-0712-7","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T04:02:22Z","timestamp":1579579342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Fluconazole Prophylaxis in Prevention of Symptomatic Candida Vaginitis"],"prefix":"10.1007","volume":"22","author":[{"given":"Kannika","family":"Story","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Sobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,21]]},"reference":[{"issue":"2","key":"712_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0002-9378(98)80001-X","volume":"178","author":"JD Sobel","year":"1998","unstructured":"Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol. 1998;178(2):203\u201311.","journal-title":"Am J Obstet Gynecol"},{"key":"712_CR2","unstructured":"Bitew, A., & Abebaw, Y. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern. BMC Women\u2019s Health, 18(1) (2018)., N.PAG. https:\/\/doi-org.proxy1.lib.tju.edu\/10.1186\/s12905-018-0607-z"},{"issue":"3","key":"712_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s11046-018-0305-2","volume":"184","author":"Liang Yan","year":"2019","unstructured":"Yan, L., Wang, X., Seyedmousavi, S., Yuan, J., Abulize, P., Pan, W., . . . Deng, S. (2019). Antifungal susceptibility profile of Candida albicans isolated from vulvovaginal candidiasis in Xinjiang Province of China. Mycopathologia,1-10. doi:https:\/\/doi.org\/10.1007\/s11046-018-0305-2.","journal-title":"Mycopathologia"},{"key":"712_CR4","unstructured":"Workowski, Kimberly. \u201cSexually transmitted diseases treatment guidelines, 2015.\u201d Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 5 June 2015, https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr6403a1.htm."},{"key":"712_CR5","doi-asserted-by":"crossref","unstructured":"Yano, J., Fidel, P. L., Fidel, P. L., Jr, Noverr, M. C., Sobel, J. D., Nyirjesy, P., \u2026 Yu, Q. (2019). Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Women\u2019s Health, 19(1), N.PAG. https:\/\/doi-org.proxy1.lib.tju.edu\/10.1186\/s12905-019-0748-8","DOI":"10.1186\/s12905-019-0748-8"},{"issue":"6","key":"712_CR6","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1097\/AOG.0b013e31827307b2","volume":"120","author":"Dror Marchaim","year":"2012","unstructured":"Marchaim D, Lemanek L, Bheemreddy S, Kaye KS, Sobel JD. (2012). Fluconazole-resistant candida albicans vulvovaginitis. Obstet Gynecol. 2012 Dec;120(6):1407-14. http:\/\/10.1097\/AOG.0b013e31827307b2.","journal-title":"Obstetrics & Gynecology"},{"key":"712_CR7","doi-asserted-by":"crossref","unstructured":"Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med. 2004;351(9):876\u201383.","DOI":"10.1056\/NEJMoa033114"},{"key":"712_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.ajog.2008.06.029","volume":"199","author":"G Donders","year":"2008","unstructured":"Donders G, Bellen G, Bytterbier G, Verguts L, Hinoul P, Walckers R, et al. Individualized decreasing maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCi-DiF trial). Am J Obstet Gynecol. 2008;199:613\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"712_CR9","unstructured":"Sobel, Jack D. \u201cCandida vulvovaginitis: treatment.\u201d UpToDate, UpToDate, 6 Mar. 2019, https:\/\/www.uptodate.com\/contents\/candida-vulvovaginitis-treatment?search=fluconazole and antibiotics&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H2855685582."},{"issue":"7","key":"712_CR10","doi-asserted-by":"publisher","first-page":"E179","DOI":"10.1503\/cmaj.180963","volume":"191","author":"Anick B\u00e9rard","year":"2019","unstructured":"B\u00e9rard A, Sheehy O, Zhao J-P, Gorgui J, Bernatsky S, de Moura CS, et al. Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies. CMAJ: Canadian Medical Association Journal. 2019;191(7):E179\u201387. https:\/\/doi-org.proxy1.lib.tju.edu\/10.1503\/cmaj.180963.","journal-title":"Canadian Medical Association Journal"},{"issue":"2","key":"712_CR11","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1086\/317936","volume":"183","author":"Jack\u00a0D. Sobel","year":"2001","unstructured":"Sobel JD, Ohmit SE, Schuman P, Klein RS, Mayer K, Duerr A, Vazquez JA, Rampalo A, HIV Epidemiology Research Study (HERS) Group (2001). The evolution of Candida spp. and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 2001;183:286\u2013293.","journal-title":"The Journal of Infectious Diseases"},{"issue":"8","key":"712_CR12","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/myc.12946","volume":"62","author":"Sofia Maraki","year":"2019","unstructured":"Maraki S, Mavromanolaki VE, Stafylaki D, Nioti E, Hamilos G, Kasimati A. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis. Mycoses. 2019. https:\/\/doi.org\/10.1111\/myc.12946.","journal-title":"Mycoses"},{"issue":"5","key":"712_CR13","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1067\/S0002-9378(03)00726-9","volume":"189","author":"Jack D Sobel","year":"2003","unstructured":"Sobel JD, Chaim W, Nagappan V, Leaman D (2003) Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. Am J Obstet Gynecol 2003 Nov;189(5):1297\u20131300.","journal-title":"American Journal of Obstetrics and Gynecology"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-020-0712-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-020-0712-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-020-0712-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T19:14:20Z","timestamp":1611083660000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-020-0712-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["712"],"URL":"https:\/\/doi.org\/10.1007\/s11908-020-0712-7","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"21 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethics Standards"}},{"value":"All authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"2"}}